Dr. Santanu Biswas, MD

Dr. Biswas practices at Swedish Cherry Hill Campus in Seattle, Washington, part of Providence Health & Services.

Dr. Biswas' NPI, 1639138944, was assigned on March 23, 2006. Dr. Biswas graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2003. Dr. Biswas' Washington license number on file is MD60985353.

Dr. Biswas' primary practice is Swedish Cherry Hill Campus, at 500 17th Avenue, Seattle, WA 98122 in King County. The practice phone is (206) 320-2000.

Dr. Biswas' primary practice is Swedish Cherry Hill Campus in Seattle, Washington, part of Providence Health & Services. Dr. Biswas is also affiliated with Swedish First Hill Campus. The medical group on file is Providence Swedish. Dmand AI also links Dr. Biswas to 3 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Biswas practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Biswas' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Biswas is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Biswas' licenses on file in 9 states: Washington, Alaska, Arizona, Idaho, Tennessee, Utah, Ohio, Illinois and Michigan.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis, chronic hypertension and coronary artery disease among the conditions Dr. Biswas treats.

CMS data shows 5,044 Medicare services from Dr. Biswas across 26 procedure codes in 2024, for 2,659 Medicare patients. Medicare paid $165,854 for them.

CMS counts 2,659 Medicare patients who saw Dr. Biswas in 2024. The largest group is 75 to 84, with 1,067 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Biswas' median patient age at 74, with 49% women.

In 2024, Dr. Biswas wrote 2,429 Medicare Part D claims for 384 patients. 86% of them were for generic drugs. CMS names the drug for 2,187 of them, across 39 drugs with 11 or more claims each, at $355,381 in total drug cost. In 2023, CMS named 2,301 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Biswas for performance year 2024, reported as part of a group. Dr. Biswas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Biswas as offering telehealth.

Dmand AI links 18 papers to Dr. Biswas, published from 2008 to 2023. 2015 was the busiest year, with 3. The most frequent topics are Coronary Artery Disease, HIV-1 and HIV Infections. Dr. Biswas has published most often in Viruses. Dr. Biswas' most frequent co-authors are Karthikeyan Ananthasubramaniam, MD, Jeffrey L. Anderson, MD and Kirk U. Knowlton, MD.

Dmand AI links Dr. Biswas to 1 clinical trial. Conditions studied include Mitral Valve Insufficiency and Heart Valve Diseases.

CMS Open Payments shows 96 general payments to Dr. Biswas from 10 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 53% of the total. Abbott Laboratories paid the most, $27,446.

Dmand AI lists 1 award for Dr. Biswas, most recently CMS Stage 1 EHR in 2013.

Dr. Biswas graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2003. Dr. Biswas is a member of ACC.

Dr. Biswas is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.